Patents by Inventor Christopher Fiore

Christopher Fiore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11053552
    Abstract: Described herein are methods that define cellular populations that are sensitive to RARA agonists and identify patient populations that will benefit from treatment with RARA agonists. The methods may comprise administering RARA agonists to patient populations.
    Type: Grant
    Filed: January 14, 2019
    Date of Patent: July 6, 2021
    Assignee: Syros Pharmaceuticals, Inc.
    Inventors: Michael Robert McKeown, Christopher Fiore, Matthew Lucas Eaton, Emily Payton Lee, Christian Fritz
  • Patent number: 10584745
    Abstract: A riser tensioner bearing is provided. The riser tensioner bearing is an asymmetric bearing having an outer member comprising a cylindrical outer profile and an at least partially spherical interior profile, and an inner member comprising an at least partially spherical outer profile and a substantially cylindrical outer profile.
    Type: Grant
    Filed: February 21, 2019
    Date of Patent: March 10, 2020
    Assignee: LORD Corporation
    Inventor: Christopher Fiore
  • Publication number: 20190316630
    Abstract: A riser tensioner bearing is provided. The riser tensioner bearing is an asymmetric bearing having an outer member comprising a cylindrical outer profile and an at least partially spherical interior profile, and an inner member comprising an at least partially spherical outer profile and a substantially cylindrical outer profile.
    Type: Application
    Filed: February 21, 2019
    Publication date: October 17, 2019
    Inventor: Christopher FIORE
  • Publication number: 20190249259
    Abstract: Described herein are methods that define cellular populations that are sensitive to RARA agonists and identify patient populations that will benefit from treatment with RARA agonists. The methods may comprise administering RARA agonists to patient populations.
    Type: Application
    Filed: January 14, 2019
    Publication date: August 15, 2019
    Inventors: Michael Robert McKeown, Christopher Fiore, Matthew Lucas Eaton, Emily Payton Lee, Christian Fritz
  • Patent number: 10240210
    Abstract: Described herein are methods that define cellular populations that are sensitive to RARA agonists and identify patient populations that will benefit from treatment with RARA agonists. The methods may comprise administering RARA agonists to patient populations.
    Type: Grant
    Filed: December 1, 2017
    Date of Patent: March 26, 2019
    Assignee: Syros Pharmaceuticals, Inc.
    Inventors: Michael Robert McKeown, Christopher Fiore, Matthew Lucas Eaton, Emily Payton Lee, Christian Fritz
  • Publication number: 20180155796
    Abstract: Described herein are methods that define cellular populations that are sensitive to RARA agonists and identify patient populations that will benefit from treatment with RARA agonists. The methods may comprise administering RARA agonists to patient populations.
    Type: Application
    Filed: December 1, 2017
    Publication date: June 7, 2018
    Inventors: Michael Robert McKeown, Christopher Fiore, Matthew Lucas Eaton, Emily Payton Lee, Christian Fritz
  • Patent number: 9868994
    Abstract: Described herein are methods that define cellular populations that are sensitive to RARA agonists and identify patient populations that will benefit from treatment with RARA agonists. The methods may comprise administering RARA agonists to patient populations.
    Type: Grant
    Filed: April 28, 2017
    Date of Patent: January 16, 2018
    Assignee: Syros Pharmaceuticals, Inc.
    Inventors: Michael Robert McKeown, Christopher Fiore, Matthew Lucas Eaton, Emily Payton Lee, Christian Fritz
  • Publication number: 20170292165
    Abstract: Described herein are methods that define cellular populations that are sensitive to RARA agonists and identify patient populations that will benefit from treatment with RARA agonists. The methods may comprise administering RARA agonists to patient populations.
    Type: Application
    Filed: April 28, 2017
    Publication date: October 12, 2017
    Inventors: Michael Robert McKeown, Christopher Fiore, Matthew Lucas Eaton, Emily Payton Lee, Christian Fritz